Table 1.
Case no. |
P / |
|
|
|
|
|
---|---|---|---|---|---|---|
/ M | Chr 9 | Chr 11 | Chr 13 | Chr 16 | Chr 18 | |
1 |
M |
- |
11q14.1-ter |
- |
16q12.1-ter |
- |
3 |
P |
9 |
- |
13q11-ter |
- |
18 |
4 |
p |
- |
- |
- |
- |
18 |
5 |
M |
- |
- |
- |
- |
18 |
6 |
M |
- |
- |
- |
16q12.2-ter |
18 |
7 |
P |
- |
11q14.1-ter |
13q33.1 |
- |
18p11.31; q12.1-ter |
8 |
P |
- |
- |
- |
- |
- |
9 |
M |
- |
11q21-ter |
- |
16q12.1-ter |
18 |
10 |
P |
|
- |
- |
- |
18 |
11 |
P |
9pter-13.2 |
11q13.4; q14.1-ter |
- |
- |
18pter-q21.31 |
12 |
P |
- |
- |
- |
- |
18 |
13 |
P |
- |
(11q23.1q-ter) |
- |
- |
(18)pter-11.23 |
14 |
P |
- |
|
- |
- |
- |
15 |
P |
- |
- |
- |
- |
18 |
16 |
P |
- |
- |
- |
- |
18q22.1 |
17 |
P |
- |
- |
- |
- |
(18pter-11.21; q11.2-23) |
18 |
P |
(9p13.1-q13.2) |
- |
13q14.11-21.32 |
- |
- |
20 |
P |
- |
- |
- |
- |
- |
21 |
M |
- |
(11q13.3-ter) q13.3-13.5; q23.3-ter |
- |
16p11.2; p11.2-11.1; q12.1-ter |
(18)pter-q11.2; q12.3-ter |
23 |
M |
- |
- |
- |
- |
- |
24 |
M |
9 |
- |
13 |
- |
18 |
25 |
P |
- |
- |
- |
- |
- |
26 |
P |
- |
- |
- |
16p11.2 |
18 |
27 |
P |
- |
11q22.1-ter |
- |
16q12.1-ter |
18pter-11.21 |
27 |
M |
- |
- |
- |
- |
- |
28 |
M |
- |
- |
- |
- |
(18)18pter-11.23; q11.1-22.4 |
29 |
P |
- |
- |
- |
- |
- |
30 |
M |
- |
- |
- |
- |
18 |
31 |
P |
(9p13.1-q12) |
- |
- |
- |
18p11.31 |
32 | M | 9p13.1-11.2 | - | - | - | 18 |
P = primary tumor; M = metastasis; chr= chromosome; Alterations written within parenthesis represent borderline alterations at the threshold.